Robert G.
- Country
- Germany
- Department
- Chirurgische Universitätsklinik Erlangen
Research Overview
- Efficacy and Safety of Doxycycline Hyclate (D-PLEX) with Standard Care in Preventing Post-Abdominal Surgery Incisional Infections: A Phase III Randomized Study
- Phase III Trial on Disease-Free Survival in Resected Pancreatic Ductal Adenocarcinoma Using Oxaliplatin or Gemcitabine-Based Chemotherapy Allocation by Transcriptomic Signature
- Phase III Trial on Preoperative Chemotherapy with Irinotecan, Oxaliplatin, and Capecitabine in Resectable Advanced Colon Cancer
Data & Insights
Has run more than one trial at 32 of 142 partner sites.
Specializations
Pancreatic Cancer Research
This investigator specializes in advanced treatment approaches for pancreatic ductal adenocarcinoma (PDAC), with particular emphasis on oligometastatic pancreatic cancer management.
- Multimodal surgical interventions
- Personalized chemotherapy strategies
- Treatment optimization for resected PDAC
The research encompasses innovative therapeutic combinations of surgery and chemotherapy protocols.
Surgical Infection Prevention
The investigator focuses on developing advanced approaches for post-surgical infection prevention, particularly in the context of abdominal procedures.
- Novel anti-infective treatments
- Surgical site infection prevention
- Post-operative care optimization
Research activities center on evaluating innovative preventive measures alongside standard care protocols.
Precision Oncology
The investigator explores treatment-specific signatures for personalizing cancer therapy, particularly in resected pancreatic cancer cases.
- Biomarker-guided therapy selection
- Chemotherapy optimization
- Disease-free survival improvement strategies
The focus includes developing criteria for optimal treatment allocation based on genetic markers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.